Drug dependence and abuse is a public health problem as revealed by reports of state police that account overdoserelated deaths for 305 during 2015. Most of the dead were caused by heroin. Despite evidence that methadone maintenance treatment is effective, it remains a controversial therapy because of its indefinite provision of a dependence-producing medication. The aim of this work is to evaluate clinically the effectiveness of Suboxone in maintaining abstinence and preventing relapse. Suboxone consists of buprenorphine and naloxone in the 4:1 ratio. The former is a partial agonist on the receptor and its absorption is rapid, while Naloxone is an antagonist on the receptor k and it is absorbed slowly. At SERT of Marsala 32 drugaddicted people were monitored. At the beginning of the monitoring, 23% of patients had already started Suboxone treatment, whereas the rest of the group was subjected to suboxone treatment for the first time. The monitoring activity included laboratory exams, questionnaires and weekly speeches. The evaluation were based on the patient’s response to Suboxone, possible side effects and degree of patient satisfaction. Even if 15% of patients have interrupted the suboxone treatment, the success of the therapy over time has been satisfactory at the time of the last report. In particular, 82% of patients who have tried both treatments with methadone and suboxone find the latter more effective. Study findings suggest that Suboxone treatment improves the ability of patients to remain abstinent, having fewer side effects with respect to methadone and reducing the risk of relapse.

Venturella, F., Spada, E., Tumbarello, M. (2017). SUBOXONE EFFICACY IN TREATING DRUG ADDICTION: COMPARISON WITH METHADONE AND MONITORING OF PATIENTS IN THERAPY AT SERT OF MARSALA. JOURNAL OF BIOLOGICAL RESEARCH, 90(Suppl. 1), 14-15.

SUBOXONE EFFICACY IN TREATING DRUG ADDICTION: COMPARISON WITH METHADONE AND MONITORING OF PATIENTS IN THERAPY AT SERT OF MARSALA

VENTURELLA, Fabio;
2017-01-01

Abstract

Drug dependence and abuse is a public health problem as revealed by reports of state police that account overdoserelated deaths for 305 during 2015. Most of the dead were caused by heroin. Despite evidence that methadone maintenance treatment is effective, it remains a controversial therapy because of its indefinite provision of a dependence-producing medication. The aim of this work is to evaluate clinically the effectiveness of Suboxone in maintaining abstinence and preventing relapse. Suboxone consists of buprenorphine and naloxone in the 4:1 ratio. The former is a partial agonist on the receptor and its absorption is rapid, while Naloxone is an antagonist on the receptor k and it is absorbed slowly. At SERT of Marsala 32 drugaddicted people were monitored. At the beginning of the monitoring, 23% of patients had already started Suboxone treatment, whereas the rest of the group was subjected to suboxone treatment for the first time. The monitoring activity included laboratory exams, questionnaires and weekly speeches. The evaluation were based on the patient’s response to Suboxone, possible side effects and degree of patient satisfaction. Even if 15% of patients have interrupted the suboxone treatment, the success of the therapy over time has been satisfactory at the time of the last report. In particular, 82% of patients who have tried both treatments with methadone and suboxone find the latter more effective. Study findings suggest that Suboxone treatment improves the ability of patients to remain abstinent, having fewer side effects with respect to methadone and reducing the risk of relapse.
Settore BIO/14 - Farmacologia
90th SIBS National Congress on Experimental biology in basic and applied research to the environment and human health
Trapani
27-28 ottobre 2017
90
Venturella, F., Spada, E., Tumbarello, M. (2017). SUBOXONE EFFICACY IN TREATING DRUG ADDICTION: COMPARISON WITH METHADONE AND MONITORING OF PATIENTS IN THERAPY AT SERT OF MARSALA. JOURNAL OF BIOLOGICAL RESEARCH, 90(Suppl. 1), 14-15.
File in questo prodotto:
File Dimensione Formato  
Suboxone.pdf

accesso aperto

Tipologia: Versione Editoriale
Dimensione 469.56 kB
Formato Adobe PDF
469.56 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/244120
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact